But will they be safe?

November 25, 2020
Before we start cooking, we're getting Dr. Michelle’s perspective on whether COVID-19 vaccines will be safe, and giving thanks for CRISPR and caregivers. (737 words, 3 minutes, 40 seconds)  Happy Thanksgiving! Good Day BIO is taking a quick break and will resume…
BIO

Before we start cooking, we're getting Dr. Michelle’s perspective on whether COVID-19 vaccines will be safe, and giving thanks for CRISPR and caregivers. (737 words, 3 minutes, 40 seconds) 

Happy Thanksgiving! Good Day BIO is taking a quick break and will resume publication on Monday, November 30. We hope you have a restful, safe holiday!

 

But will they be safe?

 
 

The biopharmaceutical industry has worked with unprecedented speed and collaboration to develop COVID-19 treatments and therapies—and at least two vaccines could be available very soon. But will they be safe? BIO President and CEO Dr. Michelle McMurry-Heath appeared on Fox News to discuss.

In the latest vaccine news, Pfizer and BioNTech applied for emergency use authorization of their COVID-19 vaccine, which could be available in as little as three weeks, according to Health and Human Services Secretary Alex Azar.

It’s not the only vaccine news we’re thankful for this week.Moderna’s vaccine also showed stellar results in its phase 3 trial, while others—like candidates from Johnson & Johnson and Novavax—are not far behind.

But will they be safe? “The U.S. Food and Drug Administration (FDA) is the gold standard in the world for regulating pharmaceuticals,” Dr. Michelle assured viewers. “The corona vaccine has been developed under more scrutiny than any other drug development process in history.”

 
BIO's Dr. Michelle on Fox News
 

The FDA will meet December 10 to publicly review the data on Pfizer and BioNTech’s vaccine, where they will “make a very informed and transparent decision,” she continued. (Here are the meeting details.

But regardless of the outcome, the other trials must continue. “It’s going to take several different vaccine candidates at our disposal to be able to vaccine at the levels that will be needed,” she said.

And when it’s available, people need to get it. “It’s not just about protecting yourself; it’s about protecting your family and your community,” she concluded.

Watch the whole thing. 

Another question: who will get the vaccine first? We discussed this yesterday in Good Day BIO and the I AM BIO Podcast.

 
Twitter
 
LinkedIn
 
Facebook
 
 

Let’s give thanks for CRISPR

 
 

Before we enjoy our Thanksgiving dinner, we want to take a moment to think about the important role that biotechnology can play in securing the global food supply and ensuring access to nutrition for everyone. Here’s an example of how one BIO member is developing breakthroughs that could help feed the world.

Meet Calyxt, the Minnesota biotech company (and BIO member) that develops crops like high oleic soybeans, which have more heart-healthy oleic acid and less saturated fat than conventional soybeans, explains Innovature.

Now, the company has developed a high-fiber wheat, “the world’s first gene-edited, consumer-focused wheat product,” reports Grand Forks Herald. It’s expected to go into commercial planting in 2022.

Calyxt has a number of innovations in the works that could help feed the world—including “better-yielding hemp, cold-tolerant oats, pulses with improved protein profiles and flavor, and alfalfa with enhanced traits including improved digestibility in livestock.”

This research is done with CRISPR, “a simple yet powerful tool for editing genomes” that allows scientists to make tiny, precise changes to an organism’s own DNA, as BIO’s Cornelia Poku says in this helpful explainer.

But policy and public opinion need to catch up: “Ag officials and scientists have tried to persuade the public, much of which is skeptical of or even worried about GMOs, to accept the use of CRISPR,” says the Grand Forks Herald.

What can we do? BIO continues to share the facts about CRISPR at Innovature and on our website, and remind policymakers of the need for workable, science-based regulations of this technology.

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 

Recognizing National Family Caregivers Month
 
 

November is National Family Caregivers Monthso today, we’re giving thanks for caregivers and the powerful role they play for patients.

“Patients are at the heart of everything we do, and many of our employees have experienced being a patient or caregiver themselves,” says UCB, the BIO member company that focuses on serious neurological and immunological diseases including epilepsy, rheumatoid arthritis, and Parkinson’s.

“My experience has made my job mean a lot more,” says Kristi Lengyel, UCB’s Head of Healthcare System Strategy, discussing her experience as a caregiver for her cousin’s wife. “Value is based on making the lives of both patients and their caregivers easier—we are a part of the solution.”

To learn more about the importance of caregiving and the work being done to grow public awareness of family caregiving issues, visit the National Alliance for Caregiving (www.caregiving.org).

 

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 
BIO Beltway Report
BIO Beltway Report
 
Paragraph (sm) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis sample link.
 

President Trump’s Wednesday: North Carolina certified election results for Trump. No public events scheduled. 

President-elect Biden’s Wednesday:Pennsylvania and Nevada certified the election results for Biden. POLITICO names a few potential contenders for his HHS pick.

What’s Happening on Capitol Hill: Thanksgiving recess.

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook